Results: The frequency of angiotensin converting enzyme II, ID and DD genotypes of all the subjects was 38.9%, 40.1% and 21.0%, respectively, but in the elderly was 43.7%, 38.8% and 17.5%, respectively.
There was no significant difference of TO and TS in the patients treated with and without angiotensin-converting enzyme inhibitor [(1.1±1.2)% vs (1.6±1.5)% and (2.9±0.9) ms/RR vs (2.8±1.0) ms/RR respectively(all P>0.05)].
Objective To investigate the association between lacunar infarction (LI) and the angiotension converting enzyme (ACE) gene from the polymorphisms of insertion (I) and decetion (D) in mongol nation patients with LI verified by MRI and CT,and investigate heredity regularity in the polymorphisms of ACE gene I/D.
To investigate whether angiotensin I converting enzyme (ACE)gene insertion/deletion(I/D)polymorphism is associated with the susceptibility to diabetes mellitus(DM),analyzed the ACE gene polymorphism in 108 patients with DM(43 patients with type 1 diabetes,65 patients with type 2 diabetes)and 196 control subjects.
Objective To investigate the relationship between angiotensin I converting enzyme(ACE) gene insertion/deletion polymorphism and serum enzyme activity in the patients with renal parenchymal hypertension.
Commonly prescribed medications for control of hypertension and congestive heart failure are inhibitors of the RAAS, including angiotensin converting enzyme inhibitors (ACE-Is) and angiotensin II (A-II) receptor antagonists.
The therapeutic benefit of RAS inhibition by angiotensin converting enzyme (ACE) inhibitors and angiotensinII (ANGII) antagonists in these conditions has been shown.
Influence of the angiotensin converting enzyme inhibitor ramipril on high-sensitivity C-reactive protein (hs-CRP) in patients wi
Differential antiplatelet effects of angiotensin converting enzyme inhibitors
Enhanced cardiac angiotensinogen gene expression and angiotensin converting enzyme activity in tachypacing-induced heart failure
Long-term efficacy of a new, fixed, very-low-dose angiotension converting enzyme inhibitor/diuretic combination as first-line th
Thus, the marked functional effects seen for vasodilator treatment with lisinopril suggest that angiotension converting enzyme inhibitors may have potential therapeutic value in the treatment of diabetic neuropathy.
We determined the acute effects of the angiotension converting enzyme inhibitor captopril on the arterial mechanics in rats at different ages, based on the exponentially tapered T-tube model.
Angiotensin I converting enzyme polymorphism effects in patients with normal pressure hydrocephalus syndrome before and after su
Serum angiotensin I converting enzyme in patients with cirrhosis of the liver in orthostasis and recumbency
Angiotensin I converting enzyme in cerebrospinal fluid of patients with neurological diseases
The angiotensin I converting enzyme activity (kininase II, EC 22.214.171.124) was measured fluorimetrically in cerebrospinal fluid (CACE) of 154 patients with neurological disorders and 27 controls.
Studies analyzing the biochemical and hemodynamic consequences of the insertion/deletion (I/D) polymorphism of the angiotensin I converting enzyme gene on angiotensin I and bradykinin metabolism have provided divergent results.